0001478242-20-000059.txt : 20200811 0001478242-20-000059.hdr.sgml : 20200811 20200811170220 ACCESSION NUMBER: 0001478242-20-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200807 FILED AS OF DATE: 20200811 DATE AS OF CHANGE: 20200811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAUB W RICHARD CENTRAL INDEX KEY: 0001181162 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 201093186 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 271341991 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-08-07 0001478242 IQVIA HOLDINGS INC. IQV 0001181162 STAUB W RICHARD C/O IQVIA HOLDINGS INC. 4820 EMPEROR BLVD. DURHAM NC 27703 0 1 0 0 See Remarks Common Stock 2020-08-07 4 M 0 7508 53.26 A 19978 D Common Stock 2020-08-07 4 M 0 2475 64.93 A 22453 D Common Stock 2020-08-07 4 M 0 3500 64.67 A 25953 D Common Stock 2020-08-07 4 S 0 13483 160.47 D 12470 D Common Stock 2020-08-07 4 M 0 14262 95.23 A 26732 D Common Stock 2020-08-07 4 M 0 6145 131.82 A 32877 D Common Stock 2020-08-07 4 S 0 6884 160.04 D 25993 D Common Stock 2020-08-07 4 D 0 13523 160.54 D 12470 D Employee Stock Option (Right to Buy) 53.26 2020-08-07 4 M 0 7508.0 0.0 D 2018-02-25 2024-02-25 Common Stock 7508.0 0 D Employee Stock Option (Right to Buy) 64.93 2020-08-07 4 M 0 2475 0.0 D 2019-03-04 2025-03-04 Common Stock 2475 0 D Employee Stock Option (Right to Buy) 64.67 2020-08-07 4 M 0 3500 0.0 D 2020-03-03 2026-03-03 Common Stock 3500 0 D Stock Appreciation Right 95.23 2020-08-07 4 M 0 14262 0.0 D 2020-02-08 2028-02-08 Common Stock 14262 7132 D Stock Appreciation Right 131.82 2020-08-07 4 M 0 6145 0.0 D 2020-02-13 2029-02-13 Common Stock 6145 12291 D The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.00 to $160.81 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.00 to $160.15 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. President, Research & Development Solutions /s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub 2020-08-11